A Relative Bioavailability Study of Bupropion Sustained Release 150 mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the rate and extent of absorption of Abrika Bupropion
150 mg sustained release tablet to that of Wellbutrin SR sustained release tablet after a
single, one-tablet dose in fasted subjects.